ValuEngine Upgrades Tivity Health (TVTY) to Hold

Tivity Health (NASDAQ:TVTY) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a report released on Tuesday.

A number of other research firms have also recently issued reports on TVTY. Cantor Fitzgerald reiterated a “buy” rating and set a $49.00 price objective on shares of Tivity Health in a research report on Monday. SunTrust Banks reiterated a “buy” rating and set a $46.00 price objective on shares of Tivity Health in a research report on Friday, August 3rd. BidaskClub upgraded shares of Tivity Health from a “sell” rating to a “hold” rating in a research report on Saturday, September 8th. Finally, Zacks Investment Research upgraded shares of Tivity Health from a “sell” rating to a “hold” rating in a research report on Tuesday, August 7th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Tivity Health currently has a consensus rating of “Buy” and an average price target of $46.67.

Shares of NASDAQ:TVTY traded up $0.02 during midday trading on Tuesday, hitting $38.79. The stock had a trading volume of 6,963 shares, compared to its average volume of 472,049. The stock has a market capitalization of $1.53 billion, a PE ratio of 23.03, a PEG ratio of 1.60 and a beta of 0.82. The company has a current ratio of 0.98, a quick ratio of 0.77 and a debt-to-equity ratio of 0.15. Tivity Health has a fifty-two week low of $31.22 and a fifty-two week high of $44.35.

Tivity Health (NASDAQ:TVTY) last issued its earnings results on Monday, November 5th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.57 by $0.02. The company had revenue of $151.50 million during the quarter, compared to analysts’ expectations of $153.87 million. Tivity Health had a net margin of 13.29% and a return on equity of 28.25%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.46 EPS. On average, research analysts predict that Tivity Health will post 2.18 EPS for the current fiscal year.

A number of hedge funds have recently added to or reduced their stakes in the stock. Globeflex Capital L P increased its position in Tivity Health by 12.4% during the 2nd quarter. Globeflex Capital L P now owns 14,500 shares of the company’s stock worth $510,000 after purchasing an additional 1,600 shares in the last quarter. State of Alaska Department of Revenue increased its position in Tivity Health by 15.6% during the 3rd quarter. State of Alaska Department of Revenue now owns 12,954 shares of the company’s stock worth $416,000 after purchasing an additional 1,745 shares in the last quarter. Principal Financial Group Inc. increased its position in Tivity Health by 0.6% during the 1st quarter. Principal Financial Group Inc. now owns 289,546 shares of the company’s stock worth $11,480,000 after purchasing an additional 1,790 shares in the last quarter. ClariVest Asset Management LLC increased its position in Tivity Health by 47.8% during the 2nd quarter. ClariVest Asset Management LLC now owns 5,879 shares of the company’s stock worth $207,000 after purchasing an additional 1,902 shares in the last quarter. Finally, Metropolitan Life Insurance Co. NY increased its position in Tivity Health by 16.8% during the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 14,231 shares of the company’s stock worth $501,000 after purchasing an additional 2,045 shares in the last quarter.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Read More: What factors cause inflation to rise?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply